AstraZeneca COVID-19 vaccine registered in Ukraine
The Oxford/AstraZeneca coronavirus vaccine has been registered by the Ministry of Health for emergency use.
The Ministry of Health reports on Facebook.
"Yesterday, February 22, 2021, the Ministry of Health of Ukraine registered a COVID-19 vaccine, Oxford/AstraZeneca, for emergency medical use. Oxford University and the British-Swedish company AstraZeneca developed the vaccine. Oxford/AstraZeneca vaccine has already been approved for emergency use. The United Kingdom, the European Union, and India have also permitted for its use," the statement said.
The ministry notes that the Oxford/AstraZeneca vaccine, produced at the Serum Institute (India), has a local (trade) name Covishield. Accordingly, the Covishield vaccine, which arrives in Ukraine on February 23, is officially registered.
On Sunday, February 21, the Minister of Health, Maksym Stepanov, stated that he had personally supervised the shipment of the first batch of AstraZeneca vaccine (CoviShield) to Ukraine from a manufacturing plant in the Indian city of Pune. According to him, 500,000 doses are now being transported to Mumbai, then there will be "a long way by cargo plane with a stop in Istanbul and the vaccine will arrive in Ukraine in the coming days."
В Україні зареєстрували вакцину Oxford/AstraZeneca (Covishield) проти COVID-19 📍Вчора, 22 лютого 2021 року,…
Posted by Міністерство охорони здоров'я України on Monday, February 22, 2021
